Feb 27, 2020 - SRPT earnings call for the period ending December 31, 2019.
Feb 27, 2020 - Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q4 2019 Results Earnings Conference Call February 26, 2020, 04:30 PM ET Company Participants Ian Estepan - Senior Vice President, Chief of Staff and Corporate
Feb 26, 2020 - Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of -72.68% and 0.02%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Feb 19, 2020 - Sarepta Therapeutics (SRPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Jan 30, 2020 - Roche's (RHHBY) performance in 2019 is driven by solid strength in new drugs, which more than offset competition from biosimilars.
Jan 20, 2020 - Investors need to pay close attention to Sarepta (SRPT) stock based on the movements in the options market lately.
Jan 14, 2020 - Sarepta Therapeutics, Inc. (NASDAQ:SRPT) JPMorgan Healthcare Conference Call January 13, 2019, 12:30 ET Company Participants Douglas Ingram - President, CEO & Director Gilmore O'Neill - EVP, R&
Jan 10, 2020 - Applied Genetic's (AGTC) gene therapy candidate shows promise in an early-stage study to treat X-linked retinitis pigmentosa, a rare eye disorder.
Dec 31, 2019 - Wall Street has high hopes for this mid-cap biotech in the coming year.
Dec 24, 2019 - Companies in the news are: ACB, APA, ITCI, SRPT